BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38360902)

  • 1. Tissue-location-specific transcription programs drive tumor dependencies in colon cancer.
    Yang L; Tu L; Bisht S; Mao Y; Petkovich D; Thursby SJ; Liang J; Patel N; Yen RC; Largent T; Zahnow C; Brock M; Gabrielson K; Salimian KJ; Baylin SB; Easwaran H
    Nat Commun; 2024 Feb; 15(1):1384. PubMed ID: 38360902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF
    Sakamoto N; Feng Y; Stolfi C; Kurosu Y; Green M; Lin J; Green ME; Sentani K; Yasui W; McMahon M; Hardiman KM; Spence JR; Horita N; Greenson JK; Kuick R; Cho KR; Fearon ER
    Elife; 2017 Jan; 6():. PubMed ID: 28072391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and Braf
    Tao Y; Kang B; Petkovich DA; Bhandari YR; In J; Stein-O'Brien G; Kong X; Xie W; Zachos N; Maegawa S; Vaidya H; Brown S; Chiu Yen RW; Shao X; Thakor J; Lu Z; Cai Y; Zhang Y; Mallona I; Peinado MA; Zahnow CA; Ahuja N; Fertig E; Issa JP; Baylin SB; Easwaran H
    Cancer Cell; 2019 Feb; 35(2):315-328.e6. PubMed ID: 30753828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct mechanisms for opposite functions of homeoproteins Cdx2 and HoxB7 in double-strand break DNA repair in colon cancer cells.
    Soret C; Martin E; Duluc I; Dantzer F; Vanier M; Gross I; Freund JN; Domon-Dell C
    Cancer Lett; 2016 May; 374(2):208-15. PubMed ID: 26902420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer.
    Ma C; Olevian D; Miller C; Herbst C; Jayachandran P; Kozak MM; Chang DT; Pai RK
    Mod Pathol; 2019 Jul; 32(8):1217-1231. PubMed ID: 30962505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice.
    Aoki K; Tamai Y; Horiike S; Oshima M; Taketo MM
    Nat Genet; 2003 Dec; 35(4):323-30. PubMed ID: 14625550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cdx2 controls expression of the protocadherin Mucdhl, an inhibitor of growth and β-catenin activity in colon cancer cells.
    Hinkel I; Duluc I; Martin E; Guenot D; Freund JN; Gross I
    Gastroenterology; 2012 Apr; 142(4):875-885.e3. PubMed ID: 22202456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development.
    Bonhomme C; Duluc I; Martin E; Chawengsaksophak K; Chenard MP; Kedinger M; Beck F; Freund JN; Domon-Dell C
    Gut; 2003 Oct; 52(10):1465-71. PubMed ID: 12970140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation instability by BRAF-mediated TET silencing and lifestyle-exposure divides colon cancer pathways.
    Noreen F; Küng T; Tornillo L; Parker H; Silva M; Weis S; Marra G; Rad R; Truninger K; Schär P
    Clin Epigenetics; 2019 Dec; 11(1):196. PubMed ID: 31842975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the tumor suppressor homeogene Cdx2 by HNF4α in intestinal cancer.
    Saandi T; Baraille F; Derbal-Wolfrom L; Cattin AL; Benahmed F; Martin E; Cardot P; Duclos B; Ribeiro A; Freund JN; Duluc I
    Oncogene; 2013 Aug; 32(32):3782-8. PubMed ID: 22986531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of CDX2 expression in colon cancer via a dominant repression pathway.
    Hinoi T; Loda M; Fearon ER
    J Biol Chem; 2003 Nov; 278(45):44608-16. PubMed ID: 12947088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdx1 inhibits human colon cancer cell proliferation by reducing beta-catenin/T-cell factor transcriptional activity.
    Guo RJ; Huang E; Ezaki T; Patel N; Sinclair K; Wu J; Klein P; Suh ER; Lynch JP
    J Biol Chem; 2004 Aug; 279(35):36865-75. PubMed ID: 15215241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The homeobox gene MEIS1 is methylated in BRAF (p.V600E) mutated colon tumors.
    Dihal AA; Boot A; van Roon EH; Schrumpf M; Fariña-Sarasqueta A; Fiocco M; Zeestraten EC; Kuppen PJ; Morreau H; van Wezel T; Boer JM
    PLoS One; 2013; 8(11):e79898. PubMed ID: 24244575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2.
    Koslowski M; Türeci O; Huber C; Sahin U
    Mol Cancer; 2009 Sep; 8():77. PubMed ID: 19781065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
    Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR
    Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing the oxygen load by treatment with myo-inositol trispyrophosphate reduces growth of colon cancer and modulates the intestine homeobox gene Cdx2.
    Derbal-Wolfrom L; Pencreach E; Saandi T; Aprahamian M; Martin E; Greferath R; Tufa E; Choquet P; Lehn JM; Nicolau C; Duluc I; Freund JN
    Oncogene; 2013 Sep; 32(36):4313-8. PubMed ID: 23045284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.
    Faber K; Bullinger L; Ragu C; Garding A; Mertens D; Miller C; Martin D; Walcher D; Döhner K; Döhner H; Claus R; Plass C; Sykes SM; Lane SW; Scholl C; Fröhling S
    J Clin Invest; 2013 Jan; 123(1):299-314. PubMed ID: 23202735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDX2 downregulation is associated with poor differentiation and MMR deficiency in colon cancer.
    Olsen J; Eiholm S; Kirkeby LT; Espersen ML; Jess P; Gögenür I; Olsen J; Troelsen JT
    Exp Mol Pathol; 2016 Feb; 100(1):59-66. PubMed ID: 26551082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of the desmocollin 2 gene expression in human colon cancer cells is relieved by the homeodomain transcription factors Cdx1 and Cdx2.
    Funakoshi S; Ezaki T; Kong J; Guo RJ; Lynch JP
    Mol Cancer Res; 2008 Sep; 6(9):1478-90. PubMed ID: 18819935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.